Laddar...
Impaired Immune Health in Survivors of Diffuse Large B-Cell Lymphoma
PURPOSE: Therapeutic advances for diffuse large B-cell lymphoma (DLBCL) have led to an increasing number of survivors. Both DLBCL and its treatments perturb the immune system, yet little is known about immune health during extended survivorship. METHODS: In this retrospective cohort study, we compar...
Sparad:
| I publikationen: | J Clin Oncol |
|---|---|
| Huvudupphovsmän: | , , , , , , , |
| Materialtyp: | Artigo |
| Språk: | Inglês |
| Publicerad: |
American Society of Clinical Oncology
2020
|
| Ämnen: | |
| Länkar: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7238489/ https://ncbi.nlm.nih.gov/pubmed/32083991 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1200/JCO.19.01937 |
| Taggar: |
Lägg till en tagg
Inga taggar, Lägg till första taggen!
|